FWP Forward Pharma A/S gains 37% May 13, 2020

Posted By: Rajesh Srivastava - Wednesday, May 13, 2020

Share

& Comment

Forward Pharma A/S operates as a biopharmaceutical company. The company engages in developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.http://www.priceseries.com/trade/FWP-Forward-Pharma-AS-stock-gains-37-percent-a-Trade-Record-by-priceSeries-2020050820200513.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.